InvestorsHub Logo
Followers 15
Posts 240
Boards Moderated 0
Alias Born 01/31/2018

Re: None

Monday, 06/22/2020 10:07:16 AM

Monday, June 22, 2020 10:07:16 AM

Post# of 232933
HIV BLA: FDA 60-day vs. 74-day letter.

We all understand that by July 11th, 74 days post the April 27th filing, the FDA will send a letter with the "PDUFA date" for the approval decision for use of leronlimab in HIV combo therapy.

Also note that if there is exceptionally good or bad news - a decision not to file, or a decision to move forward with a priority review - that is conveyed by day 60 - Saturday June 26th. It could be any day this week.

Chuckles - please confirm we read this the same.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News